伴随着妇科和乳腺恶性瘤相关的神经神经瘤综合征
Elise Peter1, Jérôme Honnorat1, Virginie Desestret1
1French Reference Center for Paraneoplastic Neurological Syndromes, Hospices Civils de Lyon, Lyon, France; Synaptopathies and Autoantibodies (SynatAc) Team, Institut MeLis, Inserm U1314, UMR CNRS 5284, University Claude Bernard Lyon 1, Lyon, France.
Handbook of clinical neurology
|March 17, 2024
概括
与妇科和乳腺癌相关的小脑瘤性变性导致严重的. 早期检测Yo抗体对于识别这些经常隐藏的恶性瘤至关重要.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 麻性神经系统综合征 (PNS) 是由癌症引发的免疫媒介疾病.
- 约氏综合征是一种神经瘤小脑退行症,与妇科和乳腺恶性瘤密切相关.
研究的目的:
- 总结一下临床表现,诊断,和底层机制的Yo 瘤性小脑退化.
- 要突出Yo抗体,特定癌症和免疫反应之间的关联.
主要方法:
- 临床病例审查和对约氏综合征诊断标准的分析.
- 审查免疫学研究调查Yo抗原及其异常表达在瘤细胞的审查.
- 检查相关瘤中免疫细胞透的情况.
主要成果:
- 通过临床表现和检测血清或脑脊液 (CSF) 中的Yo抗体来确认Yo综合征的诊断.
- 这种综合症总是与卵巢或乳腺癌有关,需要彻底和重复的瘤查.
- 自身抗体向抗原,这些抗原在瘤细胞中过度表达,这表明免疫耐受性的崩.
结论:
- 约氏综合征需要对相关的妇科或乳腺瘤进行彻底和潜在的重复搜索.
- 了解PNS的免疫和遗传特征对于开发向疗法至关重要.
相关概念视频
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
162
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
162
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
200
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
200


